Mitsubishi Tanabe Pharma Canada announces that company's oral treatment formulation for amyotrophic lateral sclerosis has been added to the provincial drug plans in New Brunswick and Nova Scotia

29 August 2023 - Mitsubishi Tanabe Pharma Canada today announced that Radicava oral suspension (edaravone) is now covered under the New ...

Read more →

More children now eligible for cystic fibrosis drug

18 July 2022 - Effective today, the Province will pay for the cystic fibrosis drug Trikafta for children aged six to ...

Read more →

Ontario, British Columbia, Nova Scotia, New Brunswick, and Newfoundland, join a growing list of provinces providing public drug plan reimbursement for Teva Canada’s Ajovy (fremanezumab), for the preventive treatment of migraine in adults

17 May 2022 - Teva Canada welcomes the recently announced public formulary coverage for Ajovy (fremanezumab) by Ontario, British Columbia, ...

Read more →

Nova Scotia becomes fifth Canadian province to implement a biosimilar switching program

5 February 2022 - The province is the latest jurisdiction to adopt a program that will require patients to switch ...

Read more →

Valeo Pharma obtains public reimbursement for Enerzair Breezhaler and Atectura Breezhaler in Quebec and Nova Scotia

15 December 2021 - Public reimbursement now includes Alberta, Quebec and Nova Scotia, representing approximately 37% of the Canadian population. ...

Read more →

Halifax man devastated after insurer reverses decision to cover $25,000 cystic fibrosis drug

13 August 2021 - Stefan Strecko says he's pleaded with Canada Life to cover cost of 'miracle' drug. ...

Read more →

N.S. father says drug-pricing 'chess game' cost his daughter her life

25 February 2020 - A father's fight to bring 'life-saving' drugs to Canada. ...

Read more →

AbbVie's Skyrizi now listed on the Nova Scotia formulary for the treatment of moderate to severe plaque psoriasis

13 February 2020 - Nova Scotia lists Skyrizi on its provincial formulary effective February 06, 2020. ...

Read more →

N.S. senior blasts province over blood thinner coverage under pharmacare

6 February 2020 - Province covers warfarin, but it requires closer monitoring than newer, more expensive alternative, apixaban. ...

Read more →

Why one Nova Scotia boy is being treated with drugs that cost $6 million a year despite a better, cheaper alternative

5 May 2019 - Last summer, Health Canada approved a haemophilia drug called Hemlibra that has the potential to change Callum ...

Read more →

Nova Scotia sets up program to help pay for take-home cancer drugs

27 February 2018 - Patient medication costs are now limited to 4% of a family’s net income under new program. ...

Read more →